Lactose Intolerance Treatment Market on Track to Surpass USD 50.3 billion by 2034 at a moderate CAGR of 5.6% | Analysis by Transparency Market Research, Inc.

Advertisement

Advances in personalized medicine approaches are leading to tailored treatments and dietary recommendations for individuals with lactose intolerance. The rise of e-commerce and online retailing provides convenient access to lactose-free products and supplements globally.

Wilmington, Delaware, United States, Transparency Market Research Inc.-, July 11, 2024 (GLOBE NEWSWIRE) — The lactose intolerance treatment market (유당불내증 치료제 시장) was projected to attain US$ 27.7 billion in 2023. It is likely to garner a 5.6% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 50.3 billion. Improvements in healthcare infrastructure and diagnostic capabilities can enhance early detection and treatment of lactose intolerance. Ongoing research in nutrition and digestive health offers opportunities for developing new treatment modalities and dietary management strategies.

Increasing understanding of genetic predispositions to lactose intolerance and their implications for personalized treatment approaches. Rising healthcare expenditure globally, allowing more individuals to afford diagnostic tests and treatment for lactose intolerance. Growing preference for natural and organic lactose-free products, driving innovation in product formulations and ingredients. Development of functional foods fortified with lactase enzymes or prebiotics to aid digestion and improve gut health.

Advertisement

Expansion of non-dairy milk alternatives (e.g., almond milk, soy milk) and dairy products with reduced lactose content. Integration of digital health solutions, such as mobile apps for symptom tracking and dietary management, enhancing patient engagement and adherence to treatment. Investment opportunities in research and development of new treatment modalities, including probiotics and gene therapies. Growth potential in expanding distribution networks for lactose-free products through supermarkets, pharmacies, and specialty health stores.

Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31331

Utilization of telemedicine and telehealth platforms for remote consultations and management of lactose intolerance symptoms, particularly in underserved regions. Rising incidence of food allergies and sensitivities, including lactose intolerance, prompting dietary modifications.

Key Findings of the Market Report

  • Development of personalized nutrition plans and dietary supplements tailored to individuals with lactose intolerance based on genetic profiling and health data.
  • Increasing demand for clean label products with transparent ingredient sourcing and minimal additives.
  • Exploration of complementary therapies such as acupuncture and herbal remedies for managing lactose intolerance symptoms.
  • Opportunities for healthcare providers to integrate lactose intolerance management into primary care practices and gastroenterology specialties.

Market Trends for Lactose Intolerance Treatment

  • By treatment type, the enzymatic lactose supplements segment is expected to boost the growth of the lactose intolerance treatment market (乳糖不耐症治療市場).
  • Enzymatic lactose supplements, such as lactase enzyme tablets or drops, effectively help individuals digest lactose-containing foods without discomfort. Their convenience and ease of use contribute to their popularity among consumers.
  • As awareness about lactose intolerance grows, more individuals are diagnosed early, leading to increased demand for enzymatic supplements as a primary treatment option.
  • Manufacturers continue to innovate with different formulations and strengths of enzymatic supplements, catering to varying levels of lactose intolerance severity and consumer preferences.
  • In terms of indication type, the primary lactose intolerance segment is expected to augment the market growth.
  • Primary lactose intolerance, also known as adult-onset lactose intolerance, is the most common form globally, affecting a significant portion of the adult population. This high prevalence drives demand for effective treatment options.
  • Primary lactose intolerance is prevalent across various ethnic groups, regions, and age groups, contributing to a broad consumer base for lactose intolerance treatments.
  • Individuals with primary lactose intolerance often adopt lactose-free or reduced-lactose diets and use lactase enzyme supplements to manage symptoms, driving market growth for these products.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31331

Global Market for Lactose Intolerance Treatment: Regional Outlook
North America

  • Growing awareness about lactose intolerance symptoms and improved diagnostic techniques lead to more individuals seeking diagnosis and treatment options.
  • Increasing health consciousness among consumers, leading to higher demand for lactose-free and reduced-lactose products and treatments.

Asia Pacific

  • Diverse dietary habits across Asia Pacific countries create opportunities for manufacturers to introduce culturally relevant lactose-free products.
  • Shifts towards Westernized diets and increased consumption of dairy products in emerging economies contribute to higher prevalence of lactose intolerance, driving market growth.

Lactose Intolerance Treatment Market: Key Players
The competitive landscape of the lactose intolerance treatment market is dynamic, characterized by innovation, strategic partnerships, and a focus on expanding market presence to meet the growing demand for effective lactose intolerance management solutions worldwide. The following companies are well known participants in the lactose intolerance treatment market:

  • Johnson & Johnson
  • Abbott Laboratories
  • AstraZeneca plc
  • Amgen Inc.
  • Novo Nordisk A/S
  • Macleods
  • Sun Pharmaceutical Industries Limited
  • Lupin
  • Walter Bushnell
  • Nature’s Way
  • Ritter Pharmaceuticals Inc.
  • Profarma
  • Recordati

Key Developments

  • In 2024, Nestlé SA launched its new precision fermentation dairy protein powder named ‘Better Whey’ under the ‘Orgain’ brand. This innovative product, categorized as a lactose-free whey isolate, marks Nestlé’s latest offering in the dairy protein market.
  • In 2023, The Brooklyn Creamery debuted a range of specialty milks aimed at meeting the demand from consumers seeking wholesome options that are lactose-free.

Email Directly Here with Detail Information: [email protected]
Lactose Intolerance Treatment Market Segmentation
Treatment Type

  • Food Supplements
  • Enzymatic Lactose Supplements
  • Others

Indication Type

  • Primary Lactose Intolerance
  • Secondary Lactose Intolerance
  • Congenital Lactose Intolerance
  • Developmental Lactose Intolerance

Route of Administration

  • Oral
  • Injectable

End User

  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others (Academic Institutes, etc.)

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=31331&ltype=S

More Trending Reports by Transparency Market Research –

Gluten Intolerance Treatment Market (Markt für die Behandlung von Glutenunverträglichkeit) – The global Gluten Intolerance Treatment Market is projected to advance at a CAGR of 13.9% from 2024 to 2034

Hemophilia Treatment Drugs Market (سوق أدوية علاج الهيموفيليا) – The global hemophilia treatment drugs market is projected to expand at a CAGR of 5.0% during the forecast period from 2023 to 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: [email protected]

Follow Us: LinkedIn| Twitter| Blog | YouTube

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.